Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures. (Q34521313)

2 August 2017

1 reference

title

Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures. (English)

1 reference

2 August 2017

0 references

Margaret Gourlay

1

1 reference

PubMed ID

16670825

2 August 2017

Nora Franceschini

series ordinal

2

1 reference

PubMed ID

16670825

2 August 2017

Yevgeniy Sheyn

series ordinal

3

1 reference

2 August 2017

3 May 2006

1 reference

2 August 2017

Clinical Rheumatology

1 reference

2 August 2017

26

1 reference

2 August 2017

2

1 reference

2 August 2017

144-153

1 reference

Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study

2 August 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-006-0315-1

Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-006-0315-1

Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-006-0315-1

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004).

21 January 2018

1 reference

12 December 2020

Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids

1 reference

12 December 2020

Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study

1 reference

12 December 2020

Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events

1 reference

12 December 2020

Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group

1 reference

12 December 2020

Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice

1 reference

12 December 2020

Osteopenia in young hypogonadal women with systemic lupus erythematosus receiving chronic steroid therapy: a randomized controlled trial comparing calcitriol and hormonal replacement therapy

1 reference

12 December 2020

Inhaled corticosteroids and hip fracture: a population-based case-control study.

1 reference

12 December 2020

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

12 December 2020

Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy?

1 reference

12 December 2020

Use of oral corticosteroids and risk of fractures.

1 reference

12 December 2020

Bone mineral density changes within six months of renal transplantation

1 reference

12 December 2020

Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study

1 reference

12 December 2020

The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin

1 reference

12 December 2020

Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis

1 reference

12 December 2020

Bisphosphonates for steroid induced osteoporosis

1 reference

12 December 2020

Prevention of corticosteroid-induced osteoporosis with alendronate in sarcoid patients

1 reference

12 December 2020

Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

1 reference

12 December 2020

Generalised bone loss in patients with early rheumatoid arthritis

1 reference

12 December 2020

Corticosteroid induced osteoporosis. Guidelines for treatment

1 reference

12 December 2020

Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients

1 reference

12 December 2020

Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial

1 reference

12 December 2020

Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases

1 reference

12 December 2020

Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy

1 reference

12 December 2020

Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study

1 reference

12 December 2020

Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy

1 reference

12 December 2020

Effects of low-dose prednisone on bone metabolism

1 reference

12 December 2020

Prevention of glucocorticoid osteoporosis: a consensus document of the Dutch Society for Rheumatology

1 reference

12 December 2020

Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis.

1 reference

12 December 2020

Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids

1 reference

12 December 2020

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

1 reference

12 December 2020

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses

1 reference

12 December 2020

Use of Clinical Risk Factors in Elderly Women with Low Bone Mineral Density to Identify Women at Higher Risk of Hip Fracture: The EPIDOS Prospective Study

1 reference

12 December 2020

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

1 reference

12 December 2020

Management of steroid-induced osteoporosis: what is the current state of play?

1 reference

12 December 2020

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial

1 reference

12 December 2020

The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis

1 reference

12 December 2020

A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids

1 reference

12 December 2020

Fractures after rheumatoid arthritis. A population-based study

1 reference

12 December 2020

Factors influencing bone loss in rheumatoid arthritis: a longitudinal study

1 reference

12 December 2020

A Meta-Analysis of Prior Corticosteroid Use and Fracture Risk

1 reference

12 December 2020

The impact of oral corticosteroid use on bone mineral density and vertebral fracture

1 reference

12 December 2020

Calcium and vitamin D for corticosteroid-induced osteoporosis

1 reference

12 December 2020

US and UK guidelines for glucocorticoid-induced osteoporosis: similarities and differences

1 reference

12 December 2020

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

1 reference

12 December 2020

Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial.

1 reference

12 December 2020

Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.

1 reference

12 December 2020

A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.

1 reference

12 December 2020

Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study

1 reference

12 December 2020

Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone

1 reference

12 December 2020

Inhaled corticosteroid use and bone-mineral density in patients with asthma

1 reference

12 December 2020

Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography

1 reference

12 December 2020

Hip fractures attributable to corticosteroid use. Study of Osteoporotic Fractures Group

1 reference

12 December 2020

Public health impact of adverse bone effects of oral corticosteroids

1 reference

12 December 2020

Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy

1 reference

12 December 2020

Vertebral Fracture Risk With Long-term Corticosteroid Therapy

1 reference

12 December 2020

Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup

1 reference

12 December 2020

Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls

1 reference

12 December 2020

Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis

1 reference

12 December 2020

Densitometry in glucocorticoid-induced osteoporosis

1 reference

12 December 2020

Osteoporosis after cardiac transplantation

1 reference

12 December 2020

Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies

1 reference

12 December 2020

Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate

1 reference

12 December 2020

Effects of inhaled glucocorticoids on bone density in premenopausal women

1 reference

12 December 2020

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis

1 reference

12 December 2020

Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids

1 reference

12 December 2020

10.1007/S10067-006-0315-1

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

16670825